BALTIMORE, Jan. 28 (HSMN NewsFeed) — Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Perindopril Erbumine tablets, 2mg, 4mg and 8mg. Commercial shipment…
Biopharmaceuticals, Generics, FDA
Lupin Pharmaceuticals, Perindopril Erbumine, ACEON, Solvay Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Lupin Receives U.S. FDA Approval For Perindopril Erbumine Tablets”
Leave a Comment